INTERMED.CAP.GRP.LS-,2625INTERMED.CAP.GRP.LS-,2625INTERMED.CAP.GRP.LS-,2625

INTERMED.CAP.GRP.LS-,2625

No trades
See on Supercharts

Price target

29.870.000.00%
The 15 analysts offering 1 year price forecasts for I2X2 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 15 analysts giving stock ratings to I2X2 in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


I2X2 EPS for the last quarter is 0.63 EUR despite the estimation of 0.98 EUR. In the next quarter EPS is expected to reach 1.09 EUR. Track more of INTERMED.CAP.GRP.LS-,2625 financials and stay on top of what is up with the company.
In the next quarter INTERMED.CAP.GRP.LS-,2625 revenue is expected to reach ‪629.66 M‬ EUR. Check out INTERMED.CAP.GRP.LS-,2625 revenue and earnings and make informed decisions.
According to analysts, I2X2 price target is 29.87 EUR with a max estimate of 33.49 EUR and a min estimate of 26.90 EUR. Check if this forecast comes true in a year, meanwhile watch INTERMED.CAP.GRP.LS-,2625 stock price chart and keep track of the current situation with I2X2 news and stock market news.
We've gathered opinions of 15 analysts rating I2X2 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.